Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Rev Med Virol ; 33(2): e2429, 2023 03.
Article in English | MEDLINE | ID: covidwho-2246418

ABSTRACT

Among the environmental factors associated with type 1 diabetes (T1D), viral infections of the gut and pancreas has been investigated most intensely, identifying enterovirus infections as the prime candidate trigger of islet autoimmunity (IA) and T1D development. However, the association between respiratory tract infections (RTI) and IA/T1D is comparatively less known. While there are significant amounts of epidemiological evidence supporting the role of respiratory infections in T1D, there remains a paucity of data characterising infectious agents at the molecular level. This gap in the literature precludes the identification of the specific infectious agents driving the association between RTI and T1D. Furthermore, the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the development of IA/T1D remains undeciphered. Here, we provide a comprehensive overview of the evidence to date, implicating RTIs (viral and non-viral) as potential risk factors for IA/T1D.


Subject(s)
COVID-19 , Diabetes Mellitus, Type 1 , Islets of Langerhans , Respiratory Tract Infections , Humans , Islets of Langerhans/pathology , COVID-19/pathology , SARS-CoV-2 , Respiratory Tract Infections/pathology
2.
N Z Med J ; 135(1565): 83-94, 2022 11 11.
Article in English | MEDLINE | ID: covidwho-2112071

ABSTRACT

AIM: To determine the feasibility and acceptability of a telehealth offer and contactless delivery of human papillomavirus (HPV) cervical screening self-test during the 2021 COVID-19 Level 4 lockdown in Auckland, New Zealand. METHODS: A small proof-of-concept study was undertaken to test telehealth approaches in never-screened, due or overdue Maori and Pacific women enrolled in a local Primary Health Organisation (PHO). Study invitation, active follow-up, nurse-led discussions, result notification and a post-test questionnaire were all delivered through telehealth. RESULTS: A sample of 197 eligible Maori and Pacific women were invited to take part, of which 86 women were successfully contacted. Sixty-six agreed to take part. Overall uptake was 61 samples returned (31.8%) and uptake of all contactable women was 70.9%. Six of the 61 HPV self-tests (9.8%) were positive, all for non 16/18 types, and were referred for cytology. Three had negative cytology results, and three with positive cytology results were referred for colposcopy. CONCLUSION: The offer of HPV self-testing during COVID-19 lockdown was both feasible and highly acceptable for Maori and Pacific women. Importantly, HPV self-testing via telehealth and mail-out, alongside other options, offers a potential pro-equity approach for addressing the impact of deferred screens due to COVID-19 and other longstanding coverage issues.


Subject(s)
Alphapapillomavirus , COVID-19 , Papillomavirus Infections , Telemedicine , Uterine Cervical Neoplasms , Female , Humans , Pregnancy , Papillomavirus Infections/diagnosis , Papillomavirus Infections/epidemiology , Papillomavirus Infections/prevention & control , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/prevention & control , Uterine Cervical Neoplasms/epidemiology , Self-Testing , Early Detection of Cancer/methods , Native Hawaiian or Other Pacific Islander , Feasibility Studies , COVID-19/diagnosis , COVID-19/epidemiology , New Zealand/epidemiology , Communicable Disease Control , Papillomaviridae , Colposcopy , Mass Screening , Disease Outbreaks , Vaginal Smears
SELECTION OF CITATIONS
SEARCH DETAIL